Pfizer Vaccine’s Benefit-Risk Assessment In Older Male Adolescents A Close Call Due To Myocarditis

 
• By Sue Sutter
Scale
US FDA concluded Comirnaty's benefits outweighed its risks in older male adolescents even under a "worst case" modeling scenario. • Source: Alamy

More from Drug Safety

More from Pink Sheet